Marketed Oral Triptans in the Acute Treatment of Migraine: A Systematic Review on Efficacy and Tolerability-Reference-Cited by-同舟云学术

Marketed Oral Triptans in the Acute Treatment of Migraine: A Systematic Review on Efficacy and Tolerability

Published:2007-09 Issue:8 Volume:47 Page:1152-1168
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache

Author:

Pascual Julio,Mateos Valentin,Roig Carles,Sanchez-del-Rio Margarita,Jiménez Dolores

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1526-4610.2007.00849.x/fullpdf

Reference57 articles.

1. Epidemiology of headache in Europe

2. 2. P Tfelt-Hansen, J Olesen, PJ Goadsby, NM Ramadan, P Tfelt-Hansen, and KMA Welch . Prioritizing acute pharmacotherapy of migraines . In: eds. Prioritizing acute pharmacotherapy of migraines , 3rd ed . Philadelphia, PA: Lippincott William & Wilkins; 2006 :515 -518 .

3. Ergotamine in the acute treatment of migraine: A review and European consensus

4. Oral triptans (serotonin 5-HT 1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential mechanisms for osteopathic manipulative treatment to alleviate migraine-like pain in female rats;Frontiers in Pain Research;2024-02-05

2. Aeromedical Risk of Migraine;Aerospace Medicine and Human Performance;2024-02-01

3. Clinical guidelines "Migraine";Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2022

4. The treatment implications of forecasting headache;Pain Management;2020-11

5. The Efficacy of Shinbaro for the Preventive Treatment of Migraine: A Pilot Study;Evidence-Based Complementary and Alternative Medicine;2019-05-13